118 related articles for article (PubMed ID: 5111993)
1. Dopamine: release from the brain in vivo by amantadine.
Von Voigtlander PF; Moore KE
Science; 1971 Oct; 174(4007):408-10. PubMed ID: 5111993
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of amantadine on d-amphetamine-induced release of dopamine from cat brain in vivo.
Gudelsky GA; McCall RB; Chiueh CC; Moore KE
Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):653-60. PubMed ID: 4456497
[No Abstract] [Full Text] [Related]
3. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
Von Voigtlander PF; Moore KE
J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
[No Abstract] [Full Text] [Related]
4. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1975 Mar; 192(3):642-53. PubMed ID: 1120962
[TBL] [Abstract][Full Text] [Related]
5. Release to the cerebral ventricles of substances with possible transmitter function in the caudate nucleus.
Portig PJ; Vogt M
J Physiol; 1969 Oct; 204(3):687-715. PubMed ID: 4309959
[TBL] [Abstract][Full Text] [Related]
6. Release by tubocurarine of dopamine and homovanillic acid from the superfused caudate nucleus.
Portig PJ; Sharman DF; Vogt M
J Physiol; 1968 Feb; 194(2):565-72. PubMed ID: 5639370
[TBL] [Abstract][Full Text] [Related]
7. The release of H 3 -dopamine from cat brain following electrical stimulation of the substantia nigra and caudate nucleus.
Moore KE; Von Voigtlander PF
Neuropharmacology; 1971 Nov; 10(6):733-41. PubMed ID: 5128028
[No Abstract] [Full Text] [Related]
8. Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.
Lupp A; Lücking CH; Koch R; Jackisch R; Feuerstein TJ
J Pharmacol Exp Ther; 1992 Nov; 263(2):717-24. PubMed ID: 1359111
[TBL] [Abstract][Full Text] [Related]
9. Release of endogenously synthesized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-amphetamine.
Chiueh CC; Moore KE
Brain Res; 1973 Feb; 50(1):221-5. PubMed ID: 4690549
[No Abstract] [Full Text] [Related]
10. Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties.
Jackisch R; Link T; Neufang B; Koch R
Arch Int Pharmacodyn Ther; 1992; 320():21-42. PubMed ID: 1284458
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of amantadine as a releasing agent or uptake blocker for H 3 -dopamine in rat brain slices.
Heikkila RE; Cohen G
Eur J Pharmacol; 1972 Nov; 20(2):156-60. PubMed ID: 4651205
[No Abstract] [Full Text] [Related]
12. Norepinephrine: release from brain by d-amphetamine in vivo.
Carr LA; Moore KE
Science; 1969 Apr; 164(3877):322-3. PubMed ID: 5776642
[TBL] [Abstract][Full Text] [Related]
13. Effects of amphetamine on the contents of norepinephrine and its metabolites in the effluent of perfused cerebral ventricles of the cat.
Carr LA; Moore KE
Biochem Pharmacol; 1970 Jul; 19(7):2361-74. PubMed ID: 5520379
[No Abstract] [Full Text] [Related]
14. Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.
Karobath ME
Eur J Pharmacol; 1974 Oct; 28(2):376-8. PubMed ID: 4424404
[No Abstract] [Full Text] [Related]
15. Blockade by reserpine of methylphenidate-induced release of brain dopamine.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1975 May; 193(2):559-63. PubMed ID: 1142104
[TBL] [Abstract][Full Text] [Related]
16. Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine.
Stone TW
Br J Pharmacol; 1976 Jan; 56(1):101-10. PubMed ID: 1252658
[TBL] [Abstract][Full Text] [Related]
17. In vivo release of endogenously synthesized catecholamines from the cat brain evoked by electrical stimulation and by d-amphetamine.
Chiueh CC; Moore KE
J Neurochem; 1974 Jul; 23(1):159-68. PubMed ID: 4852387
[No Abstract] [Full Text] [Related]
18. Appearance of 5-hydroxytryptamine and an unidentified pharmacologically active lipid acid in effluent from perfused cerebral ventricles.
Feldberg W; Myers RD
J Physiol; 1966 Jun; 184(4):837-55. PubMed ID: 5296524
[TBL] [Abstract][Full Text] [Related]
19. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
Thornburg JE; Moore KE
Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
[No Abstract] [Full Text] [Related]
20. Release of homovanillic acid from the caudate nucleus.
Portig PJ; Vogt M
J Physiol; 1968 Feb; 194(2):65-6P. PubMed ID: 5639375
[No Abstract] [Full Text] [Related]
[Next] [New Search]
